A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals

Clinical trial NCT07336615 · COMPLETED

Trial details

NCT number: NCT07336615
Sponsor: ClostraBio Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Gastrointestinal Overweight , Obesity

Start date: 2025-10-09
Primary completion: 2026-06-23
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.